Literature DB >> 7957756

In vitro development of infectious liver stages of P. yoelii and P. berghei malaria in human cell lines.

J M Calvo-Calle1, A Moreno, W M Eling, E H Nardin.   

Abstract

The preerythrocytic stages of the malaria parasite are the focus of intense efforts to identify new immunological and pharmacological methods for the control of the malaria parasite. The study of the malaria hepatic stages requires an in vitro system to facilitate the analysis of parasite/host cell interactions and the characterization of exoerythrocytic form (EEF) antigens. At the present time, only the rodent malaria, Plasmodium berghei, and the human malaria, Plasmodium vivax, develop into mature infectious EEF within established cell lines in vitro. We therefore used the rodent malaria, Plasmodium yoelii, which lacks a cell line for in vitro cultivation of EEF, to screen a series of human cell lines as potential host cells for the intracellular stage of the malaria parasite. Two human hepatomas, huH-1 and huH-2, were identified that supported the development of P. yoelii EEF which were antigenically and morphologically mature. Infectious merozoites that were shown to be capable of inducing P. yoelii blood infections in vivo developed within these in vitro EEF. In addition, mature, infectious EEF of P. berghei, but not P. yoelii, were found to develop within human HeLa cells. Preliminary results suggest that the cell lines that support the intracellular growth of P. yoelii might also serve as host cells for EEF of Plasmodium falciparum. The identification and characterization of the unique intracellular requirements for differentiation and development of P. berghei and P. yoelii EEF may provide new approaches to the prophylaxis of the human malaria species.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957756     DOI: 10.1006/expr.1994.1098

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  12 in total

Review 1.  A pre-emptive strike against malaria's stealthy hepatic forms.

Authors:  Dominique Mazier; Laurent Rénia; Georges Snounou
Journal:  Nat Rev Drug Discov       Date:  2009-11       Impact factor: 84.694

2.  Quantification of sporozoite invasion, migration, and development by microscopy and flow cytometry.

Authors:  Photini Sinnis; Patricia De La Vega; Alida Coppi; Urszula Krzych; Maria M Mota
Journal:  Methods Mol Biol       Date:  2013

Review 3.  Current therapies and future possibilities for drug development against liver-stage malaria.

Authors:  Rene Raphemot; Dora Posfai; Emily R Derbyshire
Journal:  J Clin Invest       Date:  2016-06-01       Impact factor: 14.808

4.  Extrahepatic exoerythrocytic forms of rodent malaria parasites at the site of inoculation: clearance after immunization, susceptibility to primaquine, and contribution to blood-stage infection.

Authors:  Tatiana Voza; Jessica L Miller; Stefan H I Kappe; Photini Sinnis
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

5.  Antileishmanial activity evaluation of a natural amide and its synthetic analogs against Leishmania (V.) braziliensis: an integrated approach in vitro and in silico.

Authors:  Minelly A da Silva; Harold H Fokoue; Saara N Fialho; Ana Paula de A Dos Santos; Norton R D L P Rossi; Aurileya de J Gouveia; Amália S Ferreira; Guilherme M Passarini; Ana F G Garay; Jorge J Alfonso; Andreimar M Soares; Fernando B Zanchi; Massuo J Kato; Carolina B G Teles; Christian C Kuehn
Journal:  Parasitol Res       Date:  2021-05-08       Impact factor: 2.289

6.  A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge.

Authors:  S Chatterjee; M Wery; P Sharma; V S Chauhan
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 7.  Cultivation of plasmodium spp.

Authors:  Frederick L Schuster
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

8.  Inhibitory effect of TNF-α on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinations.

Authors:  Nadya Depinay; Jean Francois Franetich; Anne Charlotte Grüner; Marjorie Mauduit; Jean-Marc Chavatte; Adrian J F Luty; Geert-Jan van Gemert; Robert W Sauerwein; Jean-Michel Siksik; Laurent Hannoun; Dominique Mazier; Georges Snounou; Laurent Rénia
Journal:  PLoS One       Date:  2011-03-04       Impact factor: 3.240

9.  The next opportunity in anti-malaria drug discovery: the liver stage.

Authors:  Emily R Derbyshire; Maria M Mota; Jon Clardy
Journal:  PLoS Pathog       Date:  2011-09-22       Impact factor: 6.823

10.  Transformation of sporozoites into early exoerythrocytic malaria parasites does not require host cells.

Authors:  Karine Kaiser; Nelly Camargo; Stefan H I Kappe
Journal:  J Exp Med       Date:  2003-04-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.